Trial intelligence / Profile preview

Ciprofloxacin plus betamethasone formulations for bacterial otitis externa

IRCT20130427013136N5Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Apr 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of ciprofloxacin and betamethasone in external otitis (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Pain, Swelling and 2 more. Started Apr 2018; status: completed.

02

Drugs

ciprofloxacinbetamethasone
03

Conditions

external otitis

Beyond the preview

Go deeper on IRCT20130427013136N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130427013136N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call